Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlos Hernando de Larramendi"'
Autor:
Mar Guilarte, Anna Sala-Cunill, María Luisa Baeza, Rosario Cabañas, María Dolores Hernández, Ethel Ibañez, Carlos Hernando de Larramendi, Ramon Lleonart, Teófilo Lobera, Luis Marqués, Blanca Sáenz de San Pedro, Jaco Botha, Irmgard Andresen, Teresa Caballero, for the IOS Study Group
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-11 (2021)
Abstract Background The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B2 receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to assess
Externí odkaz:
https://doaj.org/article/90ff5c111ba24797ac5c9aba507fb7be
Autor:
Richard F. Lockey, Ian R. Mackay, José Luis García-Abujeta, Sandra Vicario García, Carlos Hernando de Larramendi Martínez, Dennis K. Ledford, Noel R. Rose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a3fd223701d955873555a95d8723302
https://doi.org/10.1007/978-1-4614-9194-1_581
https://doi.org/10.1007/978-1-4614-9194-1_581
Autor:
Carlos Hernando, de Larramendi, Jerónimo, Carnés, José Luís, García-Abujeta, Ana, García-Endrino, Elena, Muñoz-Palomino, Angel Julio, Huertas, Enrique, Fernández-Caldas, Angel, Ferrer
Publikováno v:
International archives of allergy and immunology. 146(3)
Cases of allergy to Cannabis sativa have occasionally been reported, but both the allergenic profile and eventual cross-reactivity pattern remain unknown.To analyze the allergenic profile of a population of patients from Spain sensitized to C. sativa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7bb63e4964904c2517bca4f984f75002
https://pubmed.ncbi.nlm.nih.gov/18268387
https://pubmed.ncbi.nlm.nih.gov/18268387